Don Rockey to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Don Rockey has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.089
-
A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis. Hepatology. 2021 12; 74(6):3146-3160.
Score: 0.049
-
Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension. Hepatology. 2019 03; 69(3):1287-1299.
Score: 0.040